Cofactor Genomics - About the company
Cofactor Genomics is a series A company based in San Francisco (United States), founded in 2009 by Dave Messina. It operates as a Developer of diagnostic assays using RNA sequencing. Cofactor Genomics has raised $26.2M in funding from investors like Y Combinator, Menlo Ventures and 7percent Ventures, with a current valuation of $*****. The company has 16 active competitors, including 6 funded and 1 that has exited. Its top competitors include companies like Veracyte, HAYA Therapeutics and Alida Biosciences.
Company Details
Developer of diagnostic assays using RNA sequencing. The company's product includes ImmunoPrism is an RNA sequencing-based assay that uses predictive immune modeling to generate multidimensional biomarkers. It combines machine learning and RNA-sequencing to build gene expression models for immune cells. The company's models for key immune cells include Immune Health Expression Models, Immune Escape Genes, and Co-inhibitory molecules. The company's sequencing products include mRNAble, Total RNAble, picoRNA, FFPExact, miRNAble, RNAccess, RNAmplify, and RNAdvantage.
- Website
- cofactorgenomics.com
- Email ID
- *****@cofactorgenomics.com
- Phone Number
- +1 **********
- Registered Address
- St. Louis, Missouri
Key Metrics
Founded Year
2009
Location
San Francisco, United States
Stage
Series A
Total Funding
$26.2M in 7 rounds
Latest Funding Round
Post Money Valuation
$***** as on Jan 01, 2015
Investors
Ranked
3rd among 16 active competitors
Employee Count
13 as on Sep 30, 2026
Investment & Acquisitions
Legal entities associated with Cofactor Genomics
Cofactor Genomics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Cofactor Genomics, Inc. CIN: 474418741 , United States, Active | Jun 11, 2015 | - | 9 (As on Dec 31, 2021) | - |
Sign up to download Cofactor Genomics' company profile
Cofactor Genomics's funding and investors
Cofactor Genomics has raised a total funding of $26.2M over 7 rounds. Its first funding round was on Sep 01, 2014. Its latest funding round was a Series A round on Dec 15, 2025 for $*****. 2 investors participated in its latest round. Cofactor Genomics has 20 institutional investors.
Here is the list of recent funding rounds of Cofactor Genomics:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 15, 2025 | 4122772 | Series A | 7731542 | 2020920 | 1180800 | 5223366 |
Aug 02, 2023 | 1392109 | Series A | 8836518 | 4288070 | 6979872 | 4913155 |
Dec 16, 2021 | 9718635 | Series A | 9243937 | 2683224 | 3926014 | 2220992 |
View details of Cofactor Genomics's funding rounds and investors
Cofactor Genomics' founders and board of directors
Founder? Claim ProfileThe founders of Cofactor Genomics is Dave Messina.
Here are the details of Cofactor Genomics' key team members:
- Dave Messina: Former Co-Founder of Cofactor Genomics. They are also an angel investor in 1 startup.Contact Info: 1 email address
Cofactor Genomics' Board of Directors
Cofactor Genomics's board has 8 active members. William Hagstrom, Armen A Vidian, Mark Siegel, John Kuelper, Jarret Glasscock, Matthew A. Ocko, Jarret Glassock and David Messina are independent board members.Here is the list of Cofactor Genomics' board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 4y 10m | |
kbipsvk | Independent board member | - | Current | 3y 2m |
lfa{{lv | Independent board member | - | Current | 9y 1m |
lhcuxrt | Independent board member | - | Current | 4y 9m |
ogsdxzc | Independent board member | - | Current | 1y 2m |
jbaxxhi | Independent board member | - | Current | 3y 1m |
uqcacfo | Independent board member | - | Current | 4y 1m |
o{jdwdy | Independent board member | - | Current | 1y 8m |
View details of Cofactor Genomics's Founder profiles and Board Members
Cofactor Genomics' employee count trend
Cofactor Genomics has 13 employees as of Sep 26. Here is Cofactor Genomics's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Cofactor Genomics's Competitors and alternates
Top competitors of Cofactor Genomics include Veracyte, HAYA Therapeutics and Alida Biosciences. Here is the list of Top 10 competitors of Cofactor Genomics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Veracyte 2008, San Francisco (United States), Public | Developer of genomics-based diagnostics for cancer | $67.9M | 63/100 | |
2nd | HAYA Therapeutics 2017, Lausanne (Switzerland), Series A | Developer of RNA-based therapies for treating heart diseases | $90M | 60/100 | |
3rd | Cofactor Genomics 2009, San Francisco (United States), Series A | Developer of diagnostic assays using RNA sequencing | $26.2M | 55/100 | |
4th | Alida Biosciences 2020, San Diego (United States), Series A | Provider of technology for RNA analysis to improve human health | $11.5M | 55/100 | |
5th | Novigenix 2014, Epalinges (Switzerland), Series B | Developer of technology for cancer precision medicine | $20M | 49/100 | |
6th | Cajal Neuroscience 2020, Seattle (United States), Series A | Developer of drugs for neurodegenerative disease based on genetic screening, and multi-omics approach | $96M | 43/100 | |
7th | Isoma Diagnostics 2017, Philadelphia (United States), Funding Raised | Molecular diagnostic tests for stratification of Glioblastoma | - | 29/100 | |
8th | Biomedica Immunoassays 1992, Vienna (Austria), Unfunded | Developer of ELISAs kits for detecting circulating microRNAs | - | - | 28/100 |
9th | PeriRx 2008, Broomall (United States), Funding Raised | Developer of saliva-based risk stratification test for oral cancer | - | 27/100 | |
10th | Nova Satra 2014, Singapore (Singapore), Seed | Provider of non-invasive diagnostic tests for cancer | $2M | 25/100 |
Looking for more details on Cofactor Genomics's competitors? Click here to see the top ones
Cofactor Genomics's Investments and acquisitions
Cofactor Genomics has acquired Narus Biotechnologies. Cofactor Genomics has not made any investments as of now.Reports related to Cofactor Genomics
Here is the latest report on Cofactor Genomics's geography:
News related to Cofactor Genomics
Media has covered Cofactor Genomics for 1 event in last 1 year.
•
•
AI and RNA combine for immunotherapy breakthroughs in precision medicine, Cofactor Genomics reveals.
Business Wire•May 30, 2025•Cofactor Genomics
•
Cofactor Genomics' CEO transition aims to boost OncoPrism immunotherapy test sales and patient access.Business Wire•Jan 09, 2025•Cofactor Genomics
•
•
Cofactor Genomics Publishes Clinical Validation of OncoPrism-HNSCC, a Test Leveraging Novel RNA Modeling Technology to Predict Response to ImmunotherapyBusiness Wire•Nov 07, 2024•Cofactor Genomics
•
Cofactor Genomics receives Medicare coverage for OncoPrism®, a machine learning-based RNA oncology test predicting immunotherapy responseBusiness Wire•Oct 18, 2024•Cofactor Genomics
•
Cofactor Genomics’ Immunotherapy Predictive Diagnostic, OncoPrism, Completes Validation and Moves Into Clinical Use in Head and Neck Cancer PatientsBusiness Wire•Nov 17, 2023•Cofactor Genomics
•
Stanford University Joins Cofactor Genomics’ Clinical Trial Evaluating Immunotherapy Predictive Diagnostic Assay Across 11 CancersBusiness Wire•Jul 11, 2023•Stanford, Cofactor Genomics
•
Culmination Bio, Cofactor Genomics Team Up On Study To Advance Immunotherapy Response TestGenomeWeb•May 09, 2023•Culmination Bio, Cofactor Genomics
•
Cofactor Genomics Opens Enrollment for Non-small Cell Lung Cancer Study of OncoPrism Predictive Diagnostic AssayBusiness Wire•Dec 14, 2022•Cofactor Genomics
Are you a Founder ?
FAQs about Cofactor Genomics
Explore our recently published companies
- Saalfo Tech - Mysuru based, 2016 founded, Unfunded company
- Tolia - Thane based, 1979 founded, Unfunded company
- Krishna's Herbal & Ayurveda - Jodhpur based, 2007 founded, Unfunded company
- Bregma Science - Bengaluru based, 2016 founded, Unfunded company
- http://nordible.co - Unfunded company
- Transformative Biotech - Boulder based, 2023 founded, Unfunded company